New chief scientific officer at Viamet
This article was originally published in Scrip
Executive Summary
Dr William Moore has joined Viamet Pharmaceuticals, a US company developing metalloenzyme inhibitors, as chief scientific officer. Dr Moore has 21 years' R&D experience, primarily in early-stage companies. He was formerly chief scientific officer and vice-president of R&D at Locus Pharmaceuticals. Before that, he worked at Axys Pharmaceuticals as vice-president of target discovery and validation.